Holen Sie sich die Stockscreener-App
29.55
2.53%
0.73
Handel nachbörslich:
29.55
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Is Enovis Corporation affected by consumer sentiment2025 Market Overview & Reliable Price Breakout Signals - classian.co.kr
Will Enovis Corporation Bounce From 52 Week Low2025 Technical Patterns & AI Enhanced Trade Execution Alerts - sundaytimes.kr
What makes Enovis Corporation stock attractive today2025 Historical Comparison & Weekly Momentum Stock Picks - thegnnews.com
Enovis Corporation to Announce Q2 2025 Results via Investor Call and Webcast - MSN
Enovis Insider Buying: A Signal of Confidence Amid Uncertainty? - AInvest
Why Enovis Corporation stock attracts strong analyst attention2025 EndofYear Setup & Accurate Buy Signal Alerts - sundaytimes.kr
Executive Vice President of Strategy & Business Development of Enovis Daniel Pryor Buys 9.3% More Shares - simplywall.st
Enovis Executive Buys 9.3% More Shares, Boosting Holdings - AInvest
Enovis price target lowered to $58 from $70 at Canaccord - MSN
Enovis Shares Rise After Executive Buys 10,000 Shares - MarketScreener
Is Enovis Corporation’s ROIC above industry averageQuarterly Trade Review & AI Forecasted Stock Moves - thegnnews.com
Will Enovis Corporation benefit from AI trendsJuly 2025 Outlook & Technical Buy Zone Confirmations - thegnnews.com
Top Executive Makes Bold Move with Major Enovis Stock Purchase - TipRanks
Sector Leaders Rotate Capital Into Enovis CorporationWeekly Trend Summary & Weekly Chart Analysis and Trade Guides - newsyoung.net
Enovis: Strategic Positioning and Growth Potential Justify Buy Rating - TipRanks
Enovis (ENOV) Raises 2025 Guidance Despite Wider Losses Is Management Signaling a Strategic Shift? - simplywall.st
The Top 5 Analyst Questions From Enovis’s Q2 Earnings Call - Yahoo Finance
Enovis to Present at Three Upcoming Investor Conferences - MSN
Stocks Surge Amid Fed Interest Rate Speculation: Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Among Winners - AInvest
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - TradingView
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know | FinancialContent - FinancialContent
UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating - MSN
DENTSPLY SIRONA, Replimune Group, and Enovis Analysts Maintain Neutral Ratings - AInvest
Teleflex, Envista, Enovis, UnitedHealth Shares Surge Amid Positive Inflation Data - AInvest
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know - Yahoo Finance
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Full technical analysis of Enovis Corporation stockTop Stock Picks with Forecast Accuracy - Newser
Forecasting Enovis Corporation price range with options dataMomentum Stocks with Breakout Potential - Newser
Is Enovis Corporation meeting your algorithmic filter criteriaEntry Zone Watchlist With Momentum Focus - Newser
How to recover losses in Enovis Corporation stockMulti-Bagger Detection with Trend Tools - Newser
Will Enovis Corporation outperform the marketRisk Aware Trading Ideas with Alert Levels - Newser
Enovis Reports Strong Growth Amid Challenges, Raises Guidance - AInvest
Enovis Corporation Reports Strong Growth Amid Challenges - TipRanks
Enovis Corp's December 2026 Options Begin Trading - AInvest
Quantitative breakdown of Enovis Corporation recent moveFree AI Powered High Return Stock Calls - Newser
Using Python tools to backtest Enovis Corporation strategiesFree Swing Trading Plan With Smart Signals - Newser
How to interpret RSI for Enovis Corporation stockFast Entry Strategy with Price Prediction - Newser
Order flow analysis tools used on Enovis CorporationFree Real Market Momentum Signal Generator - Newser
Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum - MSN
What institutions are buying Enovis Corporation stock nowWeekly Price Target Forecast and Alerts - Newser
What does recent volatility data suggest for Enovis CorporationInvestment Life Cycle Planning Summary - Newser
Tick level data insight on Enovis Corporation volatilityInvestment Roadmap for High Potential Stocks - Newser
Needham & Company LLC Cuts Enovis (NYSE:ENOV) Price Target to $49.00 - Defense World
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
Earnings Release: Here's Why Analysts Cut Their Enovis Corporation (NYSE:ENOV) Price Target To US$53.40 - Yahoo Finance
Enovis Corporation (NYSE:ENOV) Q2 2025 Earnings Call Transcript - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $41 - 富途牛牛
Does Enovis Corporation stock pay reliable dividendsFree Growth Based Investment Plan Guidance - Newser
Enovis Corporation Reports Q2 2025 Financial Results - The Globe and Mail
Enovis 2025 Q2 Earnings Net Loss Widens Sharply - AInvest
Enovis' Q2 2025: Unraveling Contradictions in Recon Growth, Market Dynamics, and Financial Strategy - AInvest
Canaccord Genuity Adjusts Price Target for Enovis (ENOV) to $58. - GuruFocus
Enovis: UBS maintains Buy rating, lowers PT to $57 from $65. - AInvest
Enovis to Attend Key Investor Conferences in August and September - AInvest
Enovis (ENOV) Raises Revenue Guidance but Net Loss Widens Could Profitability Take Priority Next? - simplywall.st
Enovis Corp Inc. (ENOV) Price Performance and Its Relation to the Tech Industry - investchronicle.com
Enovis' Strategic Investor Engagement and Institutional Sentiment Shifts: A Blueprint for Medical Tech Resilience - AInvest
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating - MarketScreener
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):